Research & Development
Asgard Therapeutics appoints chief medical officer
15 April 2026 - Asgard Therapeutics, a Swedish biotech company focused on in vivo direct cell reprogramming for cancer immunotherapy, announced on Tuesday the appointment of Prof Dr Wolfram Brugger as...
CS Analytical appoints director of Scientific Affairs
15 April 2026 - CS Analytical Laboratory, a cGMP, FDA-registered and inspected contract laboratory focused on package and container testing for the pharmaceutical, biotechnology, and medical device in...
CrossBridge Bio to be acquired by Eli Lilly
14 April 2026 - CrossBridge Bio Inc, a pre-clinical biotechnology company developing next-generation dual-payload antibody-drug conjugates (ADCs), announced on Tuesday that it has entered into a defin...
IDEAYA Biosciences and Servier report positive results from Phase 2/3 trial of darovasertib/crizotinib combination
14 April 2026 - US precision medicine oncology company IDEAYA Biosciences Inc (NASDAQ:IDYA) and French pharmaceutical company Servier announced on Monday positive topline results from their Phase 2/3 ...
FDA grants priority review to ifinatamab deruxtecan in small cell lung cancer
13 April 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, and Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Monday th...
EU approves Sanofi and Regeneron's Dupixent for young children with chronic spontaneous urticaria
13 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) announced on Monday that they have rece...